Prescription Only Medication (POM)
Please select the product variation first.
Nalvee is used to help manage symptoms associated with menopause, including hot flushes, mood changes, and fatigue. It contains ingredients that support hormonal balance and overall wellbeing during menopause.
Nalvee 10mg contains dydrogesterone, a type of medicine that works in a similar way to the natural female hormone progesterone. It is used as part of hormone replacement therapy (HRT) to support an oestrogen treatment in women going through natural or surgical menopause who still have a womb. Adding dydrogesterone helps protect the lining of the womb from the effects of oestrogen. Nalvee is not suitable for men.
Have a question? We're here to help
Stop taking Nalvee and contact your doctor straight away if you develop a migraine-like or unusually severe headache, or if your vision is suddenly affected. Also contact your doctor if you notice signs of a blood clot, such as painful swelling of a leg, sudden chest pain or breathlessness. Report any changes in your breasts to your doctor. You can also report suspected side effects to the MHRA Yellow Card Scheme.
Do not take Nalvee if you are allergic to dydrogesterone or any other ingredient. You should not take it if you have or have had a tumour that grows in response to progestogen (such as a meningioma), or if you have unexplained vaginal bleeding. It is also not suitable if you have severe liver disease, certain bile pigment disorders, previous or current liver tumours, or a history of blood clots in the veins (thrombophlebitis or thromboembolic disease).
Tell your doctor before starting Nalvee if you have or have had porphyria, depression, abnormal liver function, or jaundice and itching caused by bile problems. Your doctor will need to monitor you closely. Before starting HRT, your doctor will review your full medical and family history, and may recommend regular check-ups, including breast examinations. Report any breast changes to your doctor. If you develop high blood pressure during treatment, this should be discussed with your doctor.
Nalvee 10mg is not authorised for use during pregnancy. You should not take Nalvee while breastfeeding, as progestogens and their breakdown products can pass into breast milk in small amounts, and it is not known if this could affect the baby. If you think you may be pregnant or are planning to breastfeed, speak to your doctor before taking this medicine.
If you forget to take a dose of Nalvee, take it as soon as you remember on the same day. If you do not remember until the next day, skip the missed dose and continue with your usual schedule. Do not take a double dose to make up for a forgotten one. If you are unsure what to do, speak to your doctor or pharmacist.
Nalvee does not need any special storage conditions. Keep the tablets in their original blister pack and out of the sight and reach of children. Do not use Nalvee after the expiry date printed on the packaging.
Do not throw Nalvee tablets away with household waste or flush them down the toilet. Dydrogesterone may pose a risk to the aquatic environment, so any unused or out-of-date medicine should be returned to your pharmacy for safe disposal. This helps protect the environment.
Nalvee has a minor effect on the ability to drive and use machines. Dydrogesterone may rarely cause mild drowsiness or dizziness, particularly in the first few hours after taking a tablet. If you are affected, do not drive or operate machines until you feel back to normal. Take extra care until you know how Nalvee affects you.
There is evidence that combined HRT with oestrogen and a progestogen, such as dydrogesterone, increases the risk of breast cancer. This risk becomes apparent after about 3 years of use and depends on how long you take HRT. After stopping treatment, the increased risk reduces over time. HRT can also make breasts look denser on mammograms, which may make it harder to detect breast changes. Tell your doctor about any breast changes.
HRT is linked with a higher risk of blood clots in the veins, such as deep vein thrombosis or pulmonary embolism. The risk is highest during the first year of HRT use. Risk factors include older age, major surgery, long periods of being immobile, obesity, and certain inherited clotting conditions. If you are due to have surgery or will be immobile for a long time, your doctor may stop HRT 4 to 6 weeks beforehand. Contact your doctor straight away if you notice painful swelling in a leg, sudden chest pain or breathlessness.
Common side effects include headache, migraine, nausea, menstrual changes (such as irregular or heavy bleeding) and breast pain or tenderness. Less common side effects include depressed mood, dizziness, vomiting and allergic skin reactions such as rash, itching or hives. Rare side effects include drowsiness, swelling of the breast, fluid retention, weight gain and changes in liver function. Please read the patient information leaflet for a full list of side effects.
Nalvee contains dydrogesterone, a progestogen that acts like the body’s natural hormone progesterone. When taken alongside oestrogen as part of HRT, it causes the lining of the womb to change in a controlled way. This counteracts the effect of oestrogen on the womb lining and significantly reduces the increased risk of overgrowth or cancer of the womb lining that oestrogen alone can cause.
e-Surgery uses Royal Mail delivery with choices starting from; Royal Mail 48 tracked delivery, Royal Mail tracked 24 and Royal Mail 1pm special delivery (discover more about e-Surgery delivery). When you buy products online they will arrive in discreet, recyclable packaging at a delivery address of your choice. Find out to recycle packaging from e-Surgery.
The active ingredient is dydrogesterone 10mg. The other ingredients are: lactose monohydrate, hypromellose, maize starch, colloidal anhydrous silica, magnesium stearate, macrogol and titanium dioxide.
Do not take Nalvee if any of the following apply to you:
Talk to your doctor or pharmacist before taking Nalvee if any of the following apply to you:
Same day dispatch:
0 minutes